Crossmark

Advanced Strategic Nanocarriers Containing Posaconazole as an Antifungal Drug for the Treatment of Fungal infection, Targeting topical, Ocular, Vaginal, and Systemic Delivery

Crossref DOI link: https://doi.org/10.1007/s12247-026-10405-4

Published Online: 2026-02-18

Published Print: 2026-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abd El Gawad, Mahmoud M. https://orcid.org/0009-0009-0816-0926
Shady, Ramy M. https://orcid.org/0009-0001-5790-169X
Funding

Funding for this research was provided by:

6 October University
License Information

Text and Data Mining valid from 2026-02-18

Version of Record valid from 2026-02-18
More Information

Article History

Received: 28 October 2025

Accepted: 18 January 2026

First Online: 18 February 2026

Declarations

:

: This declaration is not applicable.

: Authors declare that they have thoroughly reviewed the last version of the manuscript and have provided their consent for its submission for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below